KLTO (Klotho Neurosciences) Insider Ownership : 0.00 % (As of Dec. 13, 2024)

View and export this data going back to 2024. Start your Free Trial

What is Klotho Neurosciences Insider Ownership?

Insider ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Klotho Neurosciences's insider ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Klotho Neurosciences's Institutional Ownership is 3.78%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Klotho Neurosciences's Float Percentage Of Total Shares Outstanding is 0.00%.

Klotho Neurosciences Insider Ownership Historical Data

The historical data trend for Klotho Neurosciences's Insider Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Klotho Neurosciences Insider Ownership Chart

Klotho Neurosciences Annual Data

Trend

Dec21

Dec22

Insider Ownership

Klotho Neurosciences Quarterly Data
	Dec21	Jun22	Dec22	Jun23	Sep23	Mar24	Jun24	Sep24
Insider Ownership	Get a 7-Day Free Trial			-	-	-	-	-

Klotho Neurosciences Insider Ownership Calculation

The percentage of shares that are owned by company insiders relative to the total shares outstanding.

Klotho Neurosciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Klotho Neurosciences Inc (NAS:KLTO) » Definitions » Insider Ownership

Comparable Companies

Traded in Other Exchanges

N/A

Address

13576 Walnut Street, 12th Floor, Omaha, NE, USA, 68144

Website

https://www.klothoneuro.com

Klotho Neurosciences Inc is in the development of patented, novel disease-modifying technologies targeting the brain and central nervous system (CNS) that are seen as key developments in treating neurodegenerative and age-related disorders.